Oncogenic mutations in FBXW7 in this cohort of high‐risk endometrial cancers tended to mutual exclusivity with those in TP53 (OR = 0.53, unadjusted P = 0.12) and particularly PTEN (OR = 0.32, unadjusted P = 0.067). Here, TP53 is linked to endometrial cancer.